zyd product catalog final 102219 - zydususa
TRANSCRIPT
P R O D U C TC A T A L O G
www.zydususa.com
U P D AT E D A S O F O C T O B E R 2 0 1 9
TABLE OFCONTENTS
1 | GENERIC PRODUCTS .................................................................................................... 2
2 | THERAPEUTIC EQUIVALENCE CODES .......................... 31
3 | THERAPEUTIC CATEGORIES .................................................................. 32
4 | BRAND TO GENERIC GUIDE ................................................................... 36
5 | ORDERING INFORMATION ....................................................................... 40
6 | RETURN GOODS POLICY ............................................................................... 41
7 | CONTACT INFORMATION ........................................................................... 43
1Latex Free indicates that the container closure is not made with natural rubber latex.
TEMPERATURE CONTROLLEDSee Prescribing Information for any storage requirements on Temperature Controlled products
PRESERVATIVE FREEProduct does not contain any preservatives
LATEX FREE1
Container closure is not made with natural rubber latex
Acamprosate Calcium Delayed-Release Tablets | AB-Rated to Campral® Delayed-Release Tablets
68382-0569-28 333mg 180 24 Round; White to Off-White; 569
Acyclovir Ointment, USP | AB-Rated to Zovirax® Ointment
68382-0992-01 0.50% 15gm 48 White to Off-White
68382-0992-04 0.50% 30gm 48 White to Off-White
Acyclovir Tablets, USP | AB-Rated to Zovirax® Tablets
68382-0791-01 400mg 100 24 Round; White to Off-White; 791
68382-0791-05 400mg 500 12 Round; White to Off-White; 791
68382-0792-01 800mg 100 24 Oval; White to Off-White; 792
68382-0792-05 800mg 500 12 Oval; White to Off-White; 792
Albendazole Tablets, USP | AB-Rated to Albenza® Tablets
70710-1021-08 200mg 2 24 Round; White to Off-White; 1021
Allopurinol Tablets, USP | AB-Rated to Zyloprim® Tablets
70710-1209-01 100mg 100 24 Round; White to Off-White; 1/209 Breakline
70710-1209-00 100mg 1000 12 Round; White to Off-White; 1/209 Breakline
70710-1210-01 300mg 100 24 Round; Light Peach to Peach; 12/10 Breakline
70710-1210-05 300mg 500 12 Round; Light Peach to Peach; 12/10 Breakline
Amantadine HCl Capsules, USP | AB-Rated to Symmetrel® Capsules
68382-0512-01 100mg 100 24 Capsule; Red/Red; 652
68382-0512-05 100mg 500 12 Capsule; Red/Red; 652
Ambrisentan Tablets | AB-Rated to Letairis® Tablets
70710-1179-03 5mg 30 24 Round; Pink; 1179
70710-1180-03 10mg 30 24 Oval; White to Off-White; 1180
z y d u s u s a . c o m
2 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Amiodarone HCl Tablets | AB-Rated to Cordarone® Tablets
68382-0227-14 200mg 60 24 Round; White to Off-White; Bisect, ZE 65
68382-0227-05 200mg 500 12 Round; White to Off-White; Bisect, ZE 65
Amitriptyline HCl Tablets, USP | AB-Rated to Elavil® Tablets
70710-1225-00 10mg 1000 12 Round; White to Off-White; ZA/1
70710-1225-01 10mg 100 24 Round; White to Off-White; ZA/1
70710-1226-00 25mg 1000 12 Round; Light Green; ZA/2
70710-1226-01 25mg 100 24 Round; Light Green; ZA/2
70710-1227-00 50mg 1000 12 Round; Brown; ZA/3
70710-1227-01 50mg 100 24 Round; Brown; ZA/3
70710-1228-01 75mg 100 24 Round; Light Blue; 12 28
70710-1229-01 100mg 100 24 Round; Orange; 12 29
70710-1230-01 150mg 100 24 ModifiedCapsule-Shaped; Cream to Beige; 1230
Amlodipine Besylate Tablets, USP | AB-Rated to Norvasc® Tablets
68382-0121-16 2.5mg 90 24 Round; White to Off-White; Z/7
68382-0121-05 2.5mg 500 12 Round; White to Off-White; Z/7
68382-0122-16 5mg 90 24 Round; White to Off-White; Z3
68382-0122-05 5mg 500 12 Round; White to Off-White; Z3
68382-0123-16 10mg 90 24 Round; White to Off-White; Z5
68382-0123-05 10mg 500 12 Round; White to Off-White; Z5
Anastrozole Tablets, USP | AB-Rated to Arimidex® Tablets
68382-0209-06 1mg 30 24 Round; White; A7
Arsenic Trioxide Injection | AP-Rated to Trisenox® Injection
68382-0997-10 1mg/mL 10mL/vial x 10 12 Single-Dose Vial
70710-1610-01 2mg/mL 10mL/vial x 10 12 Single-Dose Vial
z y d u s u s a . c o m
3G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Atenolol Tablets, USP | AB-Rated to Tenormin® Tablets
68382-0022-01 25mg 100 24 Round; White to Off-White; Z/65
68382-0022-10 25mg 1000 12 Round; White to Off-White; Z/65
68382-0023-01 50mg 100 24 Round; White to Off-White; Bisect, Z 66
68382-0023-10 50mg 1000 12 Round; White to Off-White; Bisect, Z 66
68382-0024-01 100mg 100 24 Round; White to Off-White; Z 67
68382-0024-10 100mg 1000 12 Round; White to Off-White; Z 67
Atenolol/Chlorthalidone Tablets, USP | AB-Rated to Tenoretic® Tablets
70710-1167-01 50mg/25mg 100 24 Round; White to Off-White; "11"&"67"
70710-1168-01 100mg/25mg 100 24 Round; White to Off-White; "11"&"68"
Atorvastatin Calcium Tablets, USP | AB-Rated to Lipitor® Tablets
68382-0249-16 10mg 90 24 Oval; White to Off-White; 249
68382-0249-10 10mg 1000 12 Oval; White to Off-White; 249
68382-0250-16 20mg 90 24 Oval; White to Off-White; 250
68382-0250-10 20mg 1000 12 Oval; White to Off-White; 250
68382-0251-16 40mg 90 24 Oval; White to Off-White; 251
68382-0251-10 40mg 1000 12 Oval; White to Off-White; 251
68382-0252-16 80mg 90 24 Oval; White to Off-White; 252
68382-0252-10 80mg 1000 12 Oval; White to Off-White; 252
z y d u s u s a . c o m
4 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Azathioprine Tablets, USP | AB-Rated to Imuran® Tablets
68382-0003-01 50mg 100 24 Round; Yellow, Bisect; ZC 59
68382-0003-05 50mg 500 12 Round; Yellow, Bisect; ZC 59
Azithromycin Oral Suspension, USP | AB-Rated to Zithromax® Oral Suspension
70710-1457-01 100mg/5mL 15mL 24 WhitetoLightPink;Cherryflavor
70710-1458-02 200mg/5mL 15mL 24 WhitetoLightPink;Cherryflavor
70710-1459-02 200mg/5mL 22.5mL 24 WhitetoLightPink;Cherryflavor
70710-1460-02 200mg/5mL 30mL 24 WhitetoLightPink;Cherryflavor
Baclofen Tablets, USP | AB-Rated to Lioresal® Tablets
70710-1285-01 10mg 100 24 Round; White to Off-White; 1285
70710-1285-05 10mg 500 12 Round; White to Off-White; 1285
70710-1285-00 10mg 1000 12 Round; White to Off-White; 1285
70710-1286-01 20mg 100 24 Round; White to Off-White; 1286
70710-1286-05 20mg 500 12 Round; White to Off-White; 1286
70710-1286-00 20mg 1000 12 Round; White to Off-White; 1286
Benzonatate Capsules, USP | AA-Rated to Tessalon® Perles
68382-0247-01 100mg 100 24 Round; Light Yellow; Z
68382-0247-05 100mg 500 12 Round; Light Yellow; Z
Benztropine Mesylate Injection, USP | AP-Rated to Cogentin® Injection
68382-0860-10 2mg/mL 2mL/vial x 5 96 Single-Dose Vial
z y d u s u s a . c o m
5G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
6 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Betamethasone Dipropionate Cream, USP | AB-Rated to Diprosone® Cream
70710-1233-01 0.05% 15gm 48 White to Off-White
70710-1233-04 0.05% 45gm 48 White to Off-White
Bosentan Tablets | AB-Rated to Tracleer® Tablets
68382-0446-14 62.5mg 60 24 Round; Peach to Light Pink; 446
68382-0447-14 125mg 60 24 Oval; Peach to Light Pink; 447
Bromocriptine Mesylate Capsules, USP | AB-Rated to Parlodel® Capsules
68382-0110-06 5mg 30 24 Capsule; Tan/White; ZA 17/5 mg
Budesonide Capsules (Enteric Coated) | AB-Rated to Entocort® EC Capsules
68382-0720-01 3mg 100 24 Capsule; Light Orange Opaque/ White Opaque; 720
Bumetanide Tablets, USP | AB-Rated to Bumex® Tablets
68382-0525-01 0.5mg 100 24 Round; Light Green; “5”&”25”
68382-0526-01 1mg 100 24 Round; Light Yellow; “5”&”26”
68382-0527-01 2mg 100 24 Round; Light Orange; “5”&”27” Bupr
Bupropion HCl Extended-Release Tablets, USP | AB-Rated to Wellbutrin® XL Extended-Release Tablets
68382-0353-06 150mg 30 24 Round; Creamy White to Pale Yellow; 353
68382-0353-16 150mg 90 24 Round; Creamy White to Pale Yellow; 353
68382-0353-05 150mg 500 12 Round; Creamy White to Pale Yellow; 353
Buspirone HCl Tablets, USP | AB-Rated to BuSpar® Tablets
68382-0180-01 5mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 36
68382-0180-05 5mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 36
68382-0181-01 10mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 37
68382-0181-05 10mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 37
68382-0182-01 15mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 5 5 5
68382-0182-05 15mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 5 5 5
68382-0183-14 30mg 60 24 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 10 10 10
68382-0183-05 30mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 10 10 10
Carvedilol Tablets, USP | AB-Rated to Coreg® Tablets
68382-0092-01 3.125mg 100 24 Round; White to Off-White; Z/1
68382-0092-05 3.125mg 500 12 Round; White to Off-White; Z/1
68382-0093-01 6.25mg 100 24 Round; White to Off-White; ZC40
68382-0093-05 6.25mg 500 12 Round; White to Off-White; ZC40
68382-0094-01 12.5mg 100 24 Round; White to Off-White; ZC41
68382-0094-05 12.5mg 500 12 Round; White to Off-White; ZC41
68382-0095-01 25mg 100 24 Round; White to Off-White; ZC42
68382-0095-05 25mg 500 12 Round; White to Off-White; ZC42
z y d u s u s a . c o m
7G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Carmustine for Injection, USP | AP-Rated to BiCNU® Injection
70710-1525-09 100mg Kit includes one 24 Single-Dose Vial 30mL vial of of Carmustine for Carmustine for Injection, USP and Injection, USP Single-Dose Vial and one 3mL vial of Diluent of diluent
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
8 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Cholestyramine Light Powder for Suspension, USP | AB-Rated to Questran® Light Powder for Suspension
68382-0529-42 4gm 231gm 12 White; Vanilla-Orange Flavor
68382-0529-60 4gm Carton of 12 White; Vanilla-Orange Flavor 60 Pouches
Cholestyramine Powder for Suspension, USP | AB-Rated to Questran® Powder for Suspension
68382-0528-42 4gm 378gm 12 Light Yellow; Vanilla-Orange Flavor
68382-0528-60 4gm Carton of 12 Light Yellow; Vanilla-Orange Flavor 60 Pouches
Clobazam Tablets | AB-RatedtoOnfi®Tablets
70710-1325-01 10mg 100 24 Capsule-Shaped; White to Off-White;13/25
70710-1326-01 20mg 100 24 Capsule-Shaped; White to Off-White;13/26
Clobetasol Propionate Cream, USP | AB1-Rated to Temovate® Cream
70710-1456-01 0.05% 15gm 48 White to Off-White
70710-1456-02 0.05% 30gm 48 White to Off-White
70710-1456-04 0.05% 45gm 48 White to Off-White
70710-1456-03 0.05% 60gm 48 White to Off-White
Clobetasol Propionate Ointment, USP | AB-Rated to Temovate® Ointment
70710-1401-01 0.05% 15gm 48 Translucent
70710-1401-02 0.05% 30gm 48 Translucent
70710-1401-04 0.05% 45gm 48 Translucent
70710-1401-03 0.05% 60gm 48 Translucent
Clobetasol Propionate Spray | AT-Rated to Clobex® Spray
68382-0998-01 0.05% 59mL 24 Clear; Colorless
68382-0998-02 0.05% 125mL 24 Clear; Colorless
z y d u s u s a . c o m
Clomipramine HCl Capsules, USP | AB-Rated to Anafranil® Capsules
70710-1065-03 25mg 30 24 Capsule; Pink/Light Pink; 1065
70710-1065-01 25mg 100 24 Capsule; Pink/Light Pink; 1065
70710-1066-03 50mg 30 24 Capsule; Yellow/Light Pink; 1066
70710-1066-01 50mg 100 24 Capsule; Yellow/Light Pink; 1066
70710-1067-03 75mg 30 24 Capsule; Dark Pink/Light Pink; 1067
70710-1067-01 75mg 100 24 Capsule; Dark Pink/Light Pink; 1067
Cyproheptadine HCl Tablets, USP | AB-Rated to Periactin® Tablets
70710-1110-01 4mg 100 24 Round; White; 11 10/Bisect
70710-1110-00 4mg 1000 12 Round; White; 11 10/Bisect
Desmopressin Acetate Nasal Spray | AB-Rated to DDAVP® Nasal Spray
68382-0384-01 0.01% 5mL 48
Desoximetasone Ointment, USP | AB-Rated to Topicort® Ointment
68382-0889-03 0.25% 15gm 48 Off-White
68382-0889-01 0.25% 60gm 48 Off-White
68382-0889-02 0.25% 100gm 36 Off-White
9G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Dextroamphetamine Saccharate, Amphetamine Aspartate, AB-Rated toDextroamphetamine Sulfate and Amphetamine Sulfate Tablets | Adderall® Tablets
68382-0950-01 5mg 100 24 Oval; Blue; “N”&”950”
68382-0951-01 7.5mg 100 24 Round; Blue; “N”&”951”
68382-0952-01 10mg 100 24 Oval; Blue; “N”&”952”
68382-0953-01 12.5mg 100 24 Oval; Peach; “N”&”953”
68382-0954-01 15mg 100 24 Round; Peach; “N”&”954”
68382-0955-01 20mg 100 24 Oval; Peach; “N”&”955”
68382-0956-01 30mg 100 24 Oval; Peach; “N”&”956”
Diltiazem HCl Extended-Release Capsules, USP | AB-Rated to Cardizem® CD Extended-Release Capsules
68382-0595-16 120mg 90 24 Capsule; Opaque Light Green/ Opaque White; 595
68382-0595-05 120mg 500 12 Capsule; Opaque Light Green/ Opaque White; 595
68382-0596-16 180mg 90 24 Capsule; Opaque Light Blue/ Opaque Grey; 596
68382-0596-05 180mg 500 12 Capsule; Opaque Light Blue/ Opaque Grey; 596
68382-0597-16 240mg 90 24 Capsule; Opaque Light Blue/ Opaque White; 597
68382-0597-05 240mg 500 12 Capsule; Opaque Light Blue/ Opaque White; 597
68382-0598-16 300mg 90 24 Capsule; Opaque Light Green/ Opaque Grey; 598
68382-0598-05 300mg 500 12 Capsule; Opaque Light Green/ Opaque Grey; 598
68382-0599-16 360mg 90 24 Capsule; Opaque Grey/ Opaque White; 599
10
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Divalproex Sodium Capsules (Sprinkle), USP | AB-Rated to Depakote® Sprinkle Capsules
68382-0106-01 125mg 100 24 Capsule; Blue/White; ZA66/125mg
68382-0106-10 125mg 1000 12 Capsule; Blue/White; ZA66/125mg
Doxazosin Tablets, USP | AB-Rated to Cardura® Tablets
68382-0783-01 1mg 100 24 Round; White to Off-White; 783
68382-0783-10 1mg 1000 12 Round; White to Off-White; 783
68382-0784-01 2mg 100 24 Round; Light Pink to Pink; 784
68382-0784-10 2mg 1000 12 Round; Light Pink to Pink; 784
68382-0785-01 4mg 100 24 Capsule-Shaped; Light Pink to Pink; 785
68382-0785-10 4mg 1000 12 Capsule-Shaped; Light Pink to Pink; 785
68382-0786-01 8mg 100 24 Round; Light Purple to Purple; 786
68382-0786-10 8mg 1000 12 Round; Light Purple to Purple; 786
11
12 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Doxycycline for Injection, USP | AP-Rated to Doxy 100® Injection
68382-0910-10 100mg 10mL vial x 10 24 Single-Dose Vial
Doxycycline Monohydrate Capsules, USP | AB-Rated to Monodox® Capsules
68382-0782-01 50mg 100 24 Capsule; Opaque Yellow/Opaque White; 782/Plain
68382-0707-18 100mg 50 24 Capsule; Opaque Yellow/Opaque Orange; 707/Plain
Doxycycline Tablets, USP | AB-Rated to Adoxa® Tablets
70710-1121-01 50mg 100 24 Round; Off-White/Pale Yellow; 1121
70710-1122-01 75mg 100 24 Round; Light Orange/Creamish Orange; 1122
70710-1123-07 100mg 50 24 Round; Lemon Yellow/Buff; 1123
70710-1124-03 150mg 30 24 Round; Dark Orange/Creamish Orange; 1124
Duloxetine Delayed-Release Capsules, USP | AB-Rated to Cymbalta® Delayed-Release Capsules
68382-0385-14 20mg 60 24 Capsule; Green/White; 241/20 mg
68382-0386-06 30mg 30 24 Capsule; Blue/Green; 242/30 mg
68382-0387-06 60mg 30 24 Capsule; Blue/White; 243/60 mg
Dutasteride/Tamsulosin HCl Capsules | AB-rated to Jalyn® Capsules
68382-0640-06 0.5mg/0.4mg 30 24 Capsule; Opaque Yellow/Opaque White; 640
68382-0640-16 0.5mg/0.4mg 90 24 Capsule; Opaque Yellow/Opaque White; 640
Eletriptan HBr Tablets | AB-Rated to Relpax® Tablets
68382-0922-86 20mg 6 72 Round; Orange to Mottled Orange; 922
68382-0923-86 40mg 6 72 Round; Brown; 923
13G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Entecavir Tablets, USP | AB-Rated to Baraclude® Tablets
68382-0920-06 0.5mg 30 24 Round; White to Off-White; 920
68382-0921-06 1mg 30 24 Round; Light Pink to Pink; 921
Esomeprazole Magnesium Delayed-Release Capsules, USP | AB-Rated to Nexium® Delayed-Release Capsules
68382-0441-06 20mg 30 24 Capsule; Blue Opaque/White Opaque; 441/20mg
68382-0441-16 20mg 90 24 Capsule; Blue Opaque/White Opaque; 441/20mg
68382-0441-10 20mg 1000 12 Capsule; Blue Opaque/White Opaque; 441/20mg
68382-0442-06 40mg 30 24 Capsule; Blue Opaque/White Opaque; 442/40mg
68382-0442-16 40mg 90 24 Capsule; Blue Opaque/White Opaque; 442/40mg
68382-0442-10 40mg 1000 12 Capsule; Blue Opaque/White Opaque; 442/40mg
Ethacrynate Sodium for Injection, USP | AP-Rated to Edecrin® Injection
68382-0246-01 50mg 50mL vial 24 Single-Dose Vial
Etodolac Extended-Release Tablets, USP | AB-Rated to Lodine XL® Extended-Release Tablets
68382-0271-14 400mg 60 24 Oval; Orange; 271
68382-0271-01 400mg 100 24 Oval; Orange; 271
68382-0272-14 500mg 60 24 Oval; Grey; 272
68382-0272-01 500mg 100 24 Oval; Grey; 272
68382-0273-14 600mg 60 24 Oval; Blue; 273
68382-0273-01 600mg 100 24 Oval; Blue; 273
14 | G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Exemestane Tablets | AB-Rated to Aromasin® Tablets
68382-0383-06 25mg 30 24 Round; White to Off-White; 383
Ezetimibe Tablets, USP | AB-Rated to Zetia® Tablets
68382-0773-06 10mg 30 24 Capsule-Shaped; White to Off-White; 773
68382-0773-16 10mg 90 24 Capsule-Shaped; White to Off-White; 773
68382-0773-05 10mg 500 12 Capsule-Shaped; White to Off-White; 773
Fenofi brate Tablets | Same as TriCor® Tablets
68382-0269-16 48mg 90 24 Oval; Yellow; FI
68382-0270-16 145mg 90 24 Oval; White; FO
Fenofi bric Acid Delayed-Release Capsules | Same as Trilipix® Delayed-Release Capsules
68382-0232-16 45mg 90 24 Capsule; Reddish-Brown/Yellow; 45
68382-0233-16 135mg 90 24 Capsule; Blue/Yellow; 135
Fluconazole Tablets, USP | AB-RatedtoDiflucan®Tablets
70710-1137-03 50mg 30 24 Oval; Light Pink to Pink; 1137
70710-1138-03 100mg 30 24 Oval; Light Pink to Pink; 1138
70710-1138-01 100mg 100 24 Oval; Light Pink to Pink; 1138
70710-1139-08 150mg 12 24 Oval; Light Pink to Pink; 1139
70710-1140-03 200mg 30 24 Oval; Light Pink to Pink; 1140
70710-1140-01 200mg 100 24 Oval; Light Pink to Pink; 1140
z y d u s u s a . c o m
Fomepizole Injection | AP-Rated to Antizol® Injection
70710-1478-01 1.5gm/1.5mL 1.5mL/vial 24 Single-Use Vial
Gabapentin Tablets, USP | AB-Rated to Neurontin® Tablets
68382-0204-01 600mg 100 24 Oval; White to Off-White; ZE72 Bisect/Bisect
68382-0204-05 600mg 500 12 Oval; White to Off-White; ZE72 Bisect/Bisect
68382-0205-01 800mg 100 24 Oval; White to Off-White; ZE71 Bisect/Bisect
68382-0205-05 800mg 500 12 Oval; White to Off-White; ZE71 Bisect/Bisect
Glipizide Extended-Release Tablets | AB-Rated to Glucotrol® XL Extended-Release Tablets
68382-0335-06 2.5mg 30 24 Round; Yellow; 2
68382-0336-01 5mg 100 24 Round; Orange; 3 68382-0336-05 5mg 500 12 Round; Orange; 3
68382-0337-01 10mg 100 24 Round; White; 4 68382-0337-05 10mg 500 12 Round; White; 4
Glipizide/Metformin HCl Tablets, USP | AB-Rated to Metaglip® Tablets
68382-0184-01 2.5/250mg 100 24 ModifiedCapsule-Shaped;Pink;ZE68
68382-0185-01 2.5/500mg 100 24 ModifiedCapsule-Shaped;White;ZE67
68382-0186-01 5/500mg 100 24 ModifiedCapsule-Shaped;Pink;ZE66
15G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Haloperidol Tablets, USP | AB-Rated to Haloperidol Tablets, USP
68382-0079-01 5mg 100 24 Capsule-Shaped; Green; Partial Bisect, ZC 07 68382-0079-10 5mg 1000 12 Capsule-Shaped; Green; Partial Bisect, ZC 07
68382-0080-01 10mg 100 24 Capsule-Shaped; Light Green; Partial Bisect, ZC 08
68382-0081-01 20mg 100 24 Capsule-Shaped; Coral; Bisect, ZC 09
Hydroxychloroquine Sulfate Tablets, USP | AB-Rated to Plaquenil® Tablets
68382-0096-01 200mg 100 24 Capsule-Shaped; White to Off-White; ZC38
68382-0096-05 200mg 500 12 Capsule-Shaped; White to Off-White; ZC38
Indomethacin for Injection, USP | AP-Rated to Indocin® Injection
68382-0470-01 1mg 3mL vial 40 Single-Dose Vial
Isosorbide Mononitrate Extended-Release Tablets | AB-Rated to Imdur® Extended-Release Tablets
68382-0650-01 30mg 100 24 Oval; Reddish Pink; "N" Bisect "30"/ Bisect 68382-0650-05 30mg 500 12 Oval; Reddish Pink; “N” Bisect “30”/ Bisect
68382-0651-01 60mg 100 24 Oval; Yellow; ”N” Bisect “60”/ Bisect 68382-0651-05 60mg 500 12 Oval; Yellow; ”N” Bisect “60”/ Bisect
68382-0652-01 120mg 100 24 Oval; White, N120
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
16Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Labetalol HCl Tablets, USP | AB-Rated to Normodyne® Tablets
68382-0798-01 100mg 100 24 Round; Yellow; 798, Score Line
68382-0798-05 100mg 500 12 Round; Yellow; 798, Score Line
68382-0799-01 200mg 100 24 Round; White to Off-White; 799, Score Line
68382-0799-05 200mg 500 12 Round; White to Off-White; 799, Score Line
68382-0800-01 300mg 100 24 Round; Green; 800
68382-0800-05 300mg 500 12 Round; Green; 800
Lamotrigine Tablets, USP | AB-Rated to Lamictal® Tablets
68382-0006-01 25mg 100 24 Round; White to Off-White; Bisect, ZC 79
68382-0006-10 25mg 1000 12 Round; White to Off-White; Bisect, ZC 79
68382-0008-01 100mg 100 24 Round; White to Off-White; Bisect, ZC 80
68382-0008-10 100mg 1000 12 Round; White to Off-White; Bisect, ZC 80
68382-0009-14 150mg 60 24 Round; White to Off-White; Bisect, ZC 81
68382-0009-05 150mg 500 12 Round; White to Off-White; Bisect, ZC 81
68382-0010-14 200mg 60 24 Round; White to Off-White; Bisect, ZC 82
68382-0010-05 200mg 500 12 Round; White to Off-White; Bisect, ZC 82
Lansoprazole Delayed-Release Capsules, USP | AB-Rated to Prevacid® Delayed-Release Capsules
68382-0543-06 15mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-50/15mg
68382-0543-10 15mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-50/15mg
68382-0544-06 30mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-16 30mg 90 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-01 30mg 100 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-10 30mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
17Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
18Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Lansoprazole Delayed-Release | AB-Rated to Prevacid® SoluTab® Delayed-ReleaseOrally-Disintegrating Tablets Orally-Disintegrating Tablets
68382-0771-77 15mg 100 12 Round; White to Off-White; 771
68382-0772-77 30mg 100 12 Round; White to Off-White; 772
Lefl unomide Tablets, USP | AB-Rated to Arava® Tablets
70710-1157-03 10mg 30 24 Round; White to Off-White; "57"&"11"
70710-1158-03 20mg 30 24 Triangular; White to Off-White; "58"&"11"
Losartan Potassium Tablets, USP | AB-Rated to Cozaar® Tablets
68382-0135-06 25mg 30 24 Capsule-Shaped; White to Off-White; Z/2 68382-0135-16 25mg 90 24 Capsule-Shaped; White to Off-White; Z/2 68382-0135-10 25mg 1000 12 Capsule-Shaped; White to Off-White; Z/2
68382-0136-06 50mg 30 24 Capsule-Shaped; White to Off-White; Z16/Breakline 68382-0136-16 50mg 90 24 Capsule-Shaped; White to Off-White; Z16/Breakline 68382-0136-10 50mg 1000 12 Capsule-Shaped; White to Off-White; Z16/Breakline
68382-0137-06 100mg 30 24 Capsule-Shaped; White to Off-White; Z18 68382-0137-16 100mg 90 24 Capsule-Shaped; White to Off-White; Z18 68382-0137-10 100mg 1000 12 Capsule-Shaped; White to Off-White; Z18
Meloxicam Tablets, USP | AB-Rated to Mobic® Tablets
68382-0050-01 7.5mg 100 24 Round; Yellow; ZC 25
68382-0050-05 7.5mg 500 12 Round; Yellow; ZC 25
68382-0051-01 15mg 100 24 Round; Yellow; ZC 26
68382-0051-05 15mg 500 12 Round; Yellow; ZC 26
Mesalamine Delayed-Release Tablets, USP | Compare to Asacol® HD Delayed-Release Tablets
68382-0435-28 800mg 180 24 Capsule-Shaped; Red-Brown; 435
Mesalamine Delayed-Release Tablets | AB-Rated to Lialda® Delayed-Release Tablets
68382-0711-19 1.2mg 120 24 Oval-Shaped; Pale Red-Brown; 711
z y d u s u s a . c o m
Metformin HCl Tablets, USP | AB-Rated to Glucophage® Tablets
68382-0758-01 500mg 100 24 Round; White to Off-White; 70/Z
68382-0758-05 500mg 500 12 Round; White to Off-White; 70/Z
68382-0758-10 500mg 1000 12 Round; White to Off-White; 70/Z
68382-0759-01 850mg 100 24 Oval; White to Off-White; 69/Z
68382-0759-05 850mg 500 12 Oval; White to Off-White; 69/Z
68382-0759-10 850mg 1000 12 Oval; White to Off-White; 69/Z
68382-0760-01 1000mg 100 24 Oval; White to Off-White; Bisect, Z 71
68382-0760-05 1000mg 500 12 Oval; White to Off-White; Bisect, Z 71
68382-0760-10 1000mg 1000 12 Oval; White to Off-White; Bisect, Z 71
Methotrexate Tablets, USP | AB-Rated to Rheumatrex® Tablets
68382-0775-01 2.5mg 100 24 Round; Yellow; L2/Bisect
Methylprednisolone Tablets, USP | AB-Rated to Medrol® Tablets
68382-0916-34 4mg 21 36 Oval; White to Off-White; 916
68382-0916-01 4mg 100 24 Oval; White to Off-White; 916
68382-0917-11 8mg 25 24 Oval; White to Off-White; 917
68382-0918-18 16mg 50 24 Oval; White to Off-White; 918
68382-0919-11 32mg 25 24 Oval; White to Off-White; 919
Metoprolol Succinate Extended-Release Tablets, USP | AB-Rated to Toprol-XL® Extended-Release Tablets
68382-0564-01 25mg 100 24 Oval; White to Off-White; 564
68382-0564-10 25mg 1000 12 Oval; White to Off-White; 564
68382-0565-01 50mg 100 24 Round; White to Off-White; 565
68382-0565-10 50mg 1000 12 Round; White to Off-White; 565
68382-0566-01 100mg 100 24 Round; White to Off-White; 566
68382-0566-10 100mg 1000 12 Round; White to Off-White; 566
68382-0567-01 200mg 100 24 Oval; White to Off-White; “5”&“67”
68382-0567-05 200mg 500 12 Oval; White to Off-White; “5”&“67”
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
19Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Minocycline HCl Capsules, USP | AB-Rated to Minocin® Capsules
68382-0316-01 50mg 100 60 Capsule; Pink/Pink; = /316
68382-0317-01 75mg 100 60 Capsule; White/Light Gray; = /317
68382-0318-01 100mg 100 72 Capsule; Maroon/Pink; = /318
Nadolol Tablets, USP | AB-Rated to Corgard® Tablets
68382-0732-01 20mg 100 24 Round; White to Off-White; Bisect, N 20
68382-0733-01 40mg 100 24 Round; White to Off-White; Bisect, N 40
68382-0734-01 80mg 100 24 Round; White to Off-White; Bisect, N 80
Nateglinide Tablets, USP | AB-Rated to Starlix® Tablets
68382-0721-16 60mg 90 24 Round; White to Off-White; 721
68382-0722-16 120mg 90 24 Oval; Light-Orange to Orange; 722
Nitrofurantoin Capsules, USP (Macrocrystals) | AB-Rated to Macrodantin® Capsules
68382-0559-01 50mg 100 24 Capsule; Blue/White; 559
68382-0560-01 100mg 100 24 Capsule; Blue/Blue; 560
Nitroglycerin Transdermal System | Same as Nitroglycerin Transdermal System (AB2 rating)
68382-0309-30 0.2mg/HR 30 24 7cm2; Transparent Outer Backing; Nitroglycerin 0.2mg/hr
68382-0310-30 0.4mg/HR 30 24 14cm2; Transparent Outer Backing; Nitroglycerin 0.4mg/hr
68382-0311-30 0.6mg/HR 30 24 21cm2; Transparent Outer Backing; Nitroglycerin 0.6mg/hr
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
20Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Omeprazole Delayed-Release Capsules, USP | AB-Rated to Prilosec® Delayed-Release Capsules
68382-0411-01 10mg 100 24 Capsule; Amethyst Purple/White; ZA-09/10 mg
68382-0412-05 20mg 500 12 Capsule; Tan/White; ZA-10/20 mg
68382-0500-01 40mg 100 24 Capsule; Amethyst Purple/White; ZA-11/40 mg
68382-0500-10 40mg 1000 12 Capsule; Amethyst Purple/White; ZA-11/40 mg
Omeprazole/Sodium Bicarbonate Capsules | AB-Rated to Zegerid® Capsules
68382-0501-06 20/1100mg 30 24 Capsule; Opaque White/Opaque White; 501
68382-0502-06 40/1100mg 30 24 Capsule; Opaque White/Opaque White; 502
Oseltamivir Phosphate Capsules, USP | AB-RatedtoTamiflu®Capsules
70710-1008-02 30mg 10 24 Capsule; White/White; N/1008
70710-1009-02 45mg 10 24 Capsule; Light Blue Gray/Light Blue Gray; N/1009
70710-1010-02 75mg 10 24 Capsule; White/Light Blue Gray; N/1010
Oseltamivir Phosphate for Suspension | AB-RatedtoTamiflu®forSuspension
70710-1165-06 6mg/mL 60mL 24 White to Light Yellow; Tutti-Frutti Flavor
Oxybutynin Chloride Extended-Release Tablets | AB-Rated to Ditropan XL® Extended-Release Tablets
68382-0255-01 5mg 100 24 Round; White to Off-White; 255 68382-0255-05 5mg 500 12 Round; White to Off-White; 255
68382-0256-01 10mg 100 24 Round; White to Off-White; 256 68382-0256-05 10mg 500 12 Round; White to Off-White; 256
68382-0257-01 15mg 100 24 Round; White to Off-White; 257
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
21Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Paricalcitol Capsules | Same as Zemplar® Capsules
68382-0330-06 1mcg 30 48 Oval; Gray; ZA
68382-0331-06 2mcg 30 48 Oval; Orange-Brown; ZF
Paroxetine Tablets, USP | Same as Paxil® Tablets
68382-0097-06 10mg 30 24 Round; White to Off-White; Bisect, ZC 15
68382-0097-16 10mg 90 24 Round; White to Off-White; Bisect, ZC 15
68382-0097-05 10mg 500 12 Round; White to Off-White; Bisect, ZC 15
68382-0097-10 10mg 1000 12 Round; White to Off-White; Bisect, ZC 15
68382-0098-06 20mg 30 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-16 20mg 90 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-01 20mg 100 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-05 20mg 500 12 Round; White to Off-White; Bisect, ZC 16
68382-0098-10 20mg 1000 12 Round; White to Off-White; Bisect, ZC 16
68382-0099-06 30mg 30 24 Round; White to Off-White; ZC17
68382-0099-16 30mg 90 24 Round; White to Off-White; ZC17
68382-0099-05 30mg 500 12 Round; White to Off-White; ZC17
68382-0099-10 30mg 1000 12 Round; White to Off-White; ZC17
68382-0001-06 40mg 30 24 Round; White to Off-White; ZC18
68382-0001-16 40mg 90 24 Round; White to Off-White; ZC18
68382-0001-05 40mg 500 12 Round; White to Off-White; ZC18
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
22Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Phytonadione Tablets, USP | AB-Rated to Mephyton® Tablets
70710-1014-01 5mg 100 24 Round; Light Yellow to Yellow; “10”&”14”
Potassium Chloride Extended-Release Tablets, USP | Same as K-Tab® Extended-Release Tablets
68382-0776-01 8mEq (600mg) 100 48 Round; Yellow; K-TAB
68382-0776-10 8mEq (600mg) 1000 12 Round; Yellow; K-TAB
68382-0320-01 10mEq (750mg) 100 48 Ovaloid; Yellow; "10"/K-TAB
68382-0320-10 10mEq (750mg) 1000 12 Ovaloid; Yellow; "10"/K-TAB
68382-0398-01 20mEq (1500mg) 100 48 Ovaloid; White; K-TAB
68382-0398-05 20mEq (1500mg) 500 12 Ovaloid; White; K-TAB
Potassium Citrate Extended-Release Tablets, USP | AB-Rated to Urocit-K® Extended-Release Tablets
68382-0536-01 5mEq 100 24 Round; Tan to Yellowish; 536
68382-0537-01 10mEq 100 24 Oval; Tan to Yellowish; 537
68382-0538-01 15mEq 100 24 Oblong; Tan to Yellowish; 538
Pravastatin Sodium Tablets, USP | AB-Rated to Pravachol® Tablets
68382-0070-16 10mg 90 24 Oval; White to Off-White; ZC46
68382-0070-05 10mg 500 12 Oval; White to Off-White; ZC46
68382-0071-16 20mg 90 24 Oval; White to Off-White; ZC45
68382-0071-05 20mg 500 12 Oval; White to Off-White; ZC45
68382-0072-16 40mg 90 24 Oval; White to Off-White; ZC44
68382-0072-05 40mg 500 12 Oval; White to Off-White; ZC44
68382-0073-16 80mg 90 24 Oval; White to Off-White; ZC43
68382-0073-05 80mg 500 12 Oval; White to Off-White; ZC43
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
23Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Promethazine HCl Tablets, USP | AB-Rated to Phenergan® Tablets
68382-0040-01 12.5mg 100 24 Round; White to Off-White; Bisect, ZC 01
68382-0041-01 25mg 100 24 Round; White to Off-White; Quadrisect, Z C 0 2
68382-0041-10 25mg 1000 12 Round; White to Off-White; Quadrisect, Z C 0 2
68382-0042-01 50mg 100 24 Round; White to Off-White; ZC 03
Pyridostigmine Bromide Tablets, USP | AB-Rated to Mestinon® Tablets
68382-0659-06 60mg 30 24 Round; White to Off-White; Quadrisect/659
Ramelteon Tablets | AB-Rated to Rozerem® Tablets
70710-1344-03 8mg 30 24 Round; Light Yellow to Beige; 1344Ra 70710-1344-01 8mg 100 24 Round; Light Yellow to Beige; 1344
Ramipril Capsules, USP | AB-Rated to Altace® Capsules
68382-0144-06 1.25mg 30 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg
68382-0145-01 2.5mg 100 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg
68382-0146-01 5mg 100 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg
68382-0147-01 10mg 100 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg
Ranitidine Injection, USP | AP-Rated to Zantac® Injection
68382-0422-02 25mg/mL 2mL/vial x 10 1 Single-Dose Vial
68382-0423-06 25mg/mL 6mL/vial 12 Multi-Dose Vial
Ribavirin Capsules, USP | AB-Rated to Rebetol® Capsules
68382-0260-12 200mg 84 24 Capsule; White/White; ZA-12/200mg
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
24Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Ribavirin for Inhalation Solution, USP | AP-Rated to Virazole® for Inhalation Solution
68382-0395-04 6gm 100mL vial x 4 12 Glass Vial
Ribavirin Tablets | AB-Rated to Copegus® Tablets
68382-0046-03 200mg 168 24 Round; Light Pink to Pink; ZC19
Risperidone Tablets, USP | AB-Rated to Risperdal® Tablets
68382-0112-14 0.25mg 60 24 Round; Dark Yellow; Z/4 68382-0112-05 0.25mg 500 12 Round; Dark Yellow; Z/4
68382-0113-14 0.5mg 60 24 Round; Red-Brown; Z/6 68382-0113-05 0.5mg 500 12 Round; Red-Brown; Z/6
68382-0114-14 1mg 60 24 Round; White to Off-White; ZC75 68382-0114-05 1mg 500 12 Round; White to Off-White; ZC75
68382-0115-14 2mg 60 24 Round; Orange; ZC76 68382-0115-05 2mg 500 12 Round; Orange; ZC76
68382-0116-14 3mg 60 24 Round; Yellow; ZC77 68382-0116-05 3mg 500 12 Round; Yellow; ZC77
68382-0117-14 4mg 60 24 Round; Green; ZC78 68382-0117-05 4mg 500 12 Round; Green; ZC78
Rivastigmine Transdermal Patch | AB-Rated to Exelon® Transdermal Patch
70710-1196-07 4.6mg/24hr 30 24 7.75cm2; Rivastigmine Transdermal System 4.6mg/24 hours
70710-1197-07 9.5mg/24hr 30 24 16cm2; Rivastigmine Transdermal System 4.6mg/24 hours
70710-1198-07 13.3mg/24hr 30 24 22.4cm2; Rivastigmine Transdermal System 4.6mg/24 hours
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
25Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
Sirolimus Tablets | AB-Rated to Rapamune® Tablets
68382-0520-01 0.5mg 100 24 Round; Yellow; 1
Sodium Phenylacetate/Sodium Benzoate Injection | AP-Rated to Ammonul® Injection
68382-0396-01 10%/10% 50mL/vial 24 Single-Dose Vial
Spironolactone Tablets, USP | AB-Rated to Aldactone® Tablets
68382-0660-01 25mg 100 24 Round; White to Off-White; 660
68382-0660-05 25mg 500 12 Round; White to Off-White; 660
68382-0660-10 25mg 1000 12 Round; White to Off-White; 660
68382-0661-01 50mg 100 24 Oval; White to Off-White; 661
68382-0661-05 50mg 500 12 Oval; White to Off-White; 661
68382-0662-01 100mg 100 24 Round; White to Off-White; 662
68382-0662-05 100mg 500 12 Round; White to Off-White; 662
Succinylcholine Chloride Injection, USP | AP-Rated to Quelicin® Injection
70710-1377-02 20mg/mL 10mL/vial x 25 12 Multi-Dose Vial
Tadalafi l Tablets, USP | AB-Rated to Cialis® Tablets
68382-0896-06 2.5mg 30 24 Oval; White; T1
68382-0897-06 5mg 30 24 Oval; Yellow; 897
68382-0898-06 10mg 30 24 Oval; White; 898
68382-0899-06 20mg 30 24 Oval; Yellow; 899
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
26Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
AP-Rated to Ammonul® Injection
z y d u s u s a . c o m
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
27Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Tamoxifen Citrate Tablets, USP | AB-Rated to Nolvadex® Tablets
68382-0826-14 10mg 60 24 Round; White to Off-White; 826
68382-0827-06 20mg 30 24 Round; White to Off-White; 827
68382-0827-01 20mg 100 24 Round; White to Off-White; 827
Tamsulosin HCl Capsules, USP | AB-Rated to Flomax® Capsules
68382-0132-01 0.4mg 100 24 Capsule; Green/Peach; ZA-18/0.4 mg
68382-0132-10 0.4mg 1000 12 Capsule; Green/Peach; ZA-18/0.4 mg
Telmisartan Tablets, USP | AB-Rated to Micardis® Tablets
68382-0471-78 20mg 3x10 Blister Pack 36 Round; Mottled Light Brown to Mottled Brown; 471
68382-0472-78 40mg 3x10 Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 472
68382-0473-78 80mg 3x10 Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 473
Temozolomide Capsules | AB-Rated to Temodar® Capsules
68382-0751-96 5mg 5 24 Capsule; Green/White; 751
68382-0751-67 5mg 14 24 Capsule; Green/White; 751
68382-0752-96 20mg 5 24 Capsule; Yellow/White; 752
68382-0752-67 20mg 14 24 Capsule; Yellow/White; 752
68382-0753-96 100mg 5 24 Capsule; Pink/White; 753
68382-0753-67 100mg 14 24 Capsule; Pink/White; 753
68382-0754-96 140mg 5 24 Capsule; Blue/White; 754
68382-0754-67 140mg 14 24 Capsule; Blue/White; 754
68382-0755-96 180mg 5 24 Capsule; Orange/White; 755
68382-0755-67 180mg 14 24 Capsule; Orange/White; 755
68382-0756-96 250mg 5 24 Capsule; White/White; 756
z y d u s u s a . c o m
Tizanidine HCl Capsules | AB-RatedtoZanaflex®Capsules
70710-1111-08 2mg 150 24 Capsule; Light Blue/Light Blue; 1111
70710-1112-08 4mg 150 24 Capsule; Violet/White; 1112
70710-1113-08 6mg 150 24 Capsule; Violet/Violet; 1113
Topiramate Capsules (Sprinkle), USP | AB-Rated to Topamax® Sprinkle Capsules
68382-0004-14 15mg 60 24 Capsule; White Opaque/White Opaque; ZA63/15 mg
68382-0005-14 25mg 60 24 Capsule; White Opaque/White Opaque; ZA64/25 mg
Topiramate Tablets, USP | AB-Rated to Topamax® Tablets
68382-0138-14 25mg 60 24 Round; White to Off-White; ZD 16
68382-0138-05 25mg 500 12 Round; White to Off-White; ZD 16
68382-0139-14 50mg 60 24 Round; White to Off-White; ZD 15
68382-0139-05 50mg 500 12 Round; White to Off-White; ZD 15
68382-0140-14 100mg 60 24 Round; White to Off-White; ZD 14
68382-0140-05 100mg 500 12 Round; White to Off-White; ZD 14
68382-0141-14 200mg 60 24 Round; White to Off-White; ZD 13
68382-0141-05 200mg 500 12 Round; White to Off-White; ZD 13
Tramadol HCl Tablets, USP | AB-Rated to Ultram® Tablets
68382-0319-01 50mg 100 24 Round; White to Off-White; 319
68382-0319-10 50mg 1000 12 Round; White to Off-White; 319
Tramadol HCl/Acetaminophen Tablets, USP | AB-Rated to Ultracet® Tablets
68382-0334-01 37.5/325mg 100 24 Capsule-Shaped; White; 334
68382-0334-05 37.5/325mg 500 12 Capsule-Shaped; White; 334
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
28Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Trazodone HCl Tablets, USP | AB-Rated to Desyrel® Tablets
68382-0805-01 50mg 100 24 Round; White to Off-White; 805, Bisect
68382-0505-05 50mg 500 12 Round; White to Off-White; 805, Bisect
68382-0805-10 50mg 1000 12 Round; White to Off-White; 805, Bisect
68382-0806-01 100mg 100 24 Round; White to Off-White; 806, Bisect
68382-0806-05 100mg 500 12 Round; White to Off-White; 806, Bisect
68382-0806-10 100mg 1000 12 Round; White to Off-White; 806, Bisect
68382-0807-01 150mg 100 24 Oval; White to Off-White; 807, Bisect, Trisect notches/Trisect
68382-0807-05 150mg 500 12 Oval; White to Off-White; 807, Bisect, Trisect notches/Trisect
68382-0808-01 300mg 100 24 Oval; White to Off-White; 808, Bisect, Trisect notches/Trisect
Triamterene/Hydrochlorothiazide Tablets, USP | AB-Rated to Maxzide® Tablets
68382-0856-01 37.5/25mg 100 24 Round; Yellowish Green to Green; 856
68382-0856-05 37.5/25mg 500 12 Round; Yellowish Green to Green; 856
68382-0857-01 75/50mg 100 24 Round; Light Yellow to Yellow; 857
68382-0857-05 75/50mg 500 12 Round; Light Yellow to Yellow; 857
Trientine HCl Capsules, USP | AB-Rated to Syprine® Capsules
70710-1203-01 250mg 100 24 Capsule; Opaque Light Brown/Opaque White; 1203
Ursodiol Tablets, USP | AB-Rated to Urso® Forte Tablets
70710-1127-01 250mg 100 24 Oval; White to Off-White; 1127
70710-1128-01 500mg 100 24 Oval; White to Off-White; 1128
G E N E R I C P R O D U C T S |
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
29Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
Vardenafi l HCI Tablets | AB-Rated to Levitra® Tablets
70710-1068-03 2.5mg 30 24 Round; White to Off-White; 10/68
70710-1069-03 5mg 30 24 Round; Light Yellow; 10/69
70710-1070-03 10mg 30 24 Round; Light Yellow to Orange; 10/70
70710-1071-03 20mg 30 24 Round; Light Yellow to Orange; 10/71
Venlafaxine HCl Extended-Release Capsules, USP | AB-Rated to Effexor XR® Extended-Release Capsules
68382-0034-16 37.5mg 90 24 Capsule; Grey/White; ZA-35/37.5 mg
68382-0034-10 37.5mg 1000 12 Capsule; Grey/White; ZA-35/37.5 mg
68382-0035-16 75mg 90 24 Capsule; Peach/White; ZA-36/75 mg
68382-0035-10 75mg 1000 12 Capsule; Peach/White; ZA-36/75 mg
68382-0036-16 150mg 90 24 Capsule; Dark Orange/White; ZA-37/150 mg
68382-0036-10 150mg 1000 12 Capsule; Dark Orange/White; ZA-37/150 mg
Venlafaxine Tablets, USP | AB-Rated to Effexor® Tablets
68382-0018-01 25mg 100 24 Round; Peach; Bisect, ZC 64
68382-0019-01 37.5mg 100 24 Round; Peach; Bisect, ZC 65
68382-0020-01 50mg 100 24 Round; Peach; Bisect, ZC 66
68382-0021-01 75mg 100 24 Round; Peach; Bisect, ZC 67
68382-0101-01 100mg 100 24 Round; Peach; Bisect, ZC 68
Voriconazole Tablets | AB-Rated to Vfend® Tablets
68382-0735-06 50mg 30 24 Round; White to Off-White; 735
68382-0736-06 200mg 30 24 Oval; White to Off-White; 736
Zolmitriptan Orally Disintegrating Tablets | AB-Rated to Zomig-ZMT® Orally Disintegrating Tablets
68382-0715-86 2.5mg 1x6 Blister Pack 72 Round; White/Mottled White to Cream White; 715
68382-0717-82 5mg 1x3 Blister Pack 72 Round; White/Mottled White to Cream White; 717
| G E N E R I C P R O D U C T S
NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE
30Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.
z y d u s u s a . c o m
The following coding system is used for drug products that the FDA considers to be therapeutically equivalent to other pharmaceutically equivalent products. Approved drug products are considered to be therapeutic equivalents when they are pharmaceutical equivalents, have demonstrated bioequivalence, and can be expected to have the same clinical effect and safety profi le.1
A Codes - Products that are considered to be therapeutically equivalent to other pharmaceutically equivalent products
1. Orange Book Preface. Updated May 5th, 2019. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm#TEC. Accessed February 22, 2019.
T H E R A P E U T I C E Q U I V A L E N C E C O D E S |
THERAPEUTIC EQUIVALENCE CODES
31
z y d u s u s a . c o m
AA Products in conventional dosage forms not presenting bioequivalence problems
AB Products meeting necessary bioequivalence requirements
AB1 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading
AB2 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading
AB3 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading
AB4 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading
AN Solutions and powders for aerosolization
AO Injectable oil solutions
AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
AT Topical products
B Codes - Products requiring further FDA investigation and review to determine therapeutic equivalence
BC Extended-release dosage forms (capsules, injectables and tablets)
BD Active ingredients and dosage forms with documented bioequivalence problems
BE Delayed-release oral dosage forms
BN Products in aerosol-nebulizer drug delivery systems
BP Active ingredients and dosage forms with potential bioequivalence problems
BR Suppositories or enemas that deliver drugs for systemic absorption
BS Productshavingdrugstandarddeficiencies
BT Topical products with bioequivalence issues
BX Drugproductsforwhichthedataareinsufficienttodeterminetherapeuticequivalence
| T H E R A P E U T I C C A T E G O R I E S
Adrenals Budesonide Capsules (Enteric Coated) Entocort® EC Capusles
Alpha-Adrenergic Blocking Agents Doxazosin Tablets, USP Cardura® Tablets
Alpha-Adrenergic Blocking Agents Dutasteride/Tamsulosin HCl Capsules Jalyn® Capsules
Alpha-Adrenergic Blocking Agents Tamsulosin HCl Capsules, USP Flomax® Capsules
Ammonia Detoxicants Sodium Phenylacetate/Sodium Benzoate Injection Ammonul® Injection
Amphetamines Dextroamphetamine Saccharate, Amphetamine Aspartate, Adderall® Tablets Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Angiotensin II Receptor Antagonists Losartan Potassium Tablets, USP Cozaar® Tablets
Angiotensin II Receptor Antagonists Telmisartan Tablets, USP Micardis® Tablets
Anthelmintics Albendazole Tablets, USP Albenza® Tablets
Antiarrhythmic Agents Amiodarone HCl Tablets Cordarone® Tablets
Antibacterials; Tetracyclines Doxycycline Hyclate Injection, USP Doxy 100® Injection
Antibacterials; Tetracyclines Doxycycline Monohydrate Capsules, USP Monodox® Capsules
Antibacterials; Tetracyclines Doxycycline Monohydrate Tablets, USP Adoxa® Tablets
Antibacterials; Tetracyclines Minocycline HCl Capsules, USP Minocin® Capsules
Anticonvulsants ClobazamTablets Onfi®Tablets
Anticonvulsants Divalproex Sodium Capsules (Sprinkle), USP Depakote® Sprinkle Capsules
Anticonvulsants Gabapentin Tablets, USP Neurontin® Tablets
Anticonvulsants Lamotrigine Tablets, USP Lamictal® Tablets
Anticonvulsants Topiramate Capsules (Sprinkle), USP Topamax® Sprinkle Capsules
Anticonvulsants Topiramate Tablets, USP Topamax® Tablets
Antidepressants Amitriptyline HCl Tablets, USP Elavil® Tablets
Antidepressants Bupropion HCl Extended-Release Tablets, USP Wellbutrin® XL Extended-Release Tablets
Antidepressants Clomipramine HCl Capsules, USP Anafranil® Capsules
Antidepressants Duloxetine Delayed-Release Capsules, USP Cymbalta® Delayed-Release Capsules
Antidepressants Paroxetine Tablets, USP Paxil® Tablets
Antidepressants Trazodone HCl Tablets, USP Desyrel® Tablets
Antidepressants Venlafaxine HCl Extended-Release Capsules, USP Effexor XR® Extended-Release Capsules
Antidepressants Venlafaxine HCl Tablets, USP Effexor® Tablets
Antidiabetic Agents Metformin HCl Tablets, USP Glucophage® Tablets
Antidiabetics Glipizide Extended-Release Tablets Glucotrol® XL Extended-Release Tablets
Therapeutic Category Generic Name Brand Name
Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).
32
z y d u s u s a . c o m
Antidiabetics Glipizide/Metformin HCl Tablets, USP Metaglip® Tablets
Antidiabetics Nateglinide Tablets, USP Starlix® Tablets
Antidotes Fomepizole Injection Antizol® Injection
Antifungals FluconazoleTablets,USP Diflucan®Tablets
Antifungals Voriconazole Tablets Vfend® Tablets
Antigout Agents Allopurinol Tablets, USP Zyloprim® Tablets
Anti-inflammatoryAgents ClobetasolPropionateOintment,USP Temovate®Ointment
Anti-inflammatoryAgents ClobetasolPropionateSpray Clobex®Spray
Anti-inflammatoryAgents ClobetasolPropionateCream,USP Temovate®Cream
Anti-inflammatoryAgents MesalamineDelayed-ReleaseTablets Lialda®Delayed-ReleaseTablets
Anti-inflammatoryAgents MesalamineDelayed-ReleaseTablets,USP Asacol®HDDelayed-ReleaseTablets
Antilipemic Agents Atorvastatin Calcium Tablets, USP Lipitor® Tablets
Antilipemic Agents Cholestyramine Light Powder for Suspension Questran® Light Powder for Suspension
Antilipemic Agents Cholestyramine Powder for Suspension, USP Questran® Powder for Suspension
AntilipemicAgents FenofibrateTablets TriCor®Tablets
Antilipemic Agents Pravastatin Sodium Tablets, USP Pravachol® Tablets
Antimalarials Carmustine Injection, USP BiCNU® Injection
Antimigraine Agents Eletriptan HBr Tablets Relpax® Tablets
Antimigraine Agents Zolmitriptan Orally Disintegrating Tablets Zomig-ZMT® Orally Disintegrating Tablets
Antimuscarinics Oxybutynin Chloride Extended-Release Tablets Ditropan XL® Extended-Release Tablets
Antineoplastic Agents Arsenic Trioxide Injection Trisenox® Injection
Antineoplastic Agents Methotrexate Tablets, USP Rheumatrex® Tablets
Antineoplastic Agents Tamoxifen Citrate Tablets, USP Nolvadex® Tablets
Antineoplastic Agents Temozolomide Capsules Temodar® Capsules
Antiparkinson Agents; Antivirals Amantadine HCl Capsules, USP Symmetrel® Capsules
Antiparkinsonian Agents Benztropine Mesylate Injection Cogentin® Injection
Antiparkinsonian Agents Bromocriptine Mesylate Capsules, USP Parlodel® Capsules
Antipsychotic Agents Haloperidol Tablets, USP Haloperidol Tablets, USP
Antipsychotic Agents Risperidone Tablets, USP Risperdal® Tablets
Antitussives Benzonatate Capsules, USP Tessalon® Perles
Therapeutic Category Generic Name Brand Name
Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).
T H E R A P E U T I C C A T E G O R I E S | 33
z y d u s u s a . c o m
Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).
| T H E R A P E U T I C C A T E G O R I E S
Anti-inflammatoryAgents BetamethasoneDipropionateCream,USP Diprosone®Cream
Anti-inflammatoryAgents DesoximetasoneOintment,USP Topicort®Ointment
Antiulcer Agents/Acid Suppressants Methylprednisolone Tablets, USP Medrol® Tablets
Antivirals Acyclovir Ointment, USP Zovirax® Ointment
Antivirals Acyclovir Tablets, USP Zovirax® Tablets
Antivirals Entecavir Tablets Baraclude® Tablets
Antivirals OseltamivirPhosphateCapsules,USP Tamiflu®Capsules
Antivirals OseltamivirPhosphateforSuspension Tamiflu®forSuspension
Antivirals Ribavirin Capsules, USP Rebetol® Capsules
Antivirals Ribavirin for Inhalation Solution, USP Virazole® for Inhalation Solution
Antivirals Ribavirin Tablets Copegus® Tablets
Anxiolytics, Sedatives, and Hypnotics Buspirone HCl Tablets, USP BuSpar® Tablets
Anxiolytics, Sedatives, and Hypnotics Ramelteon Tablets Rozerem® Tablets
Beta-Adrenergic Blocking Agents Atenolol Tablets, USP Tenormin® Tablets
Beta-Adrenergic Blocking Agents Carvedilol Tablets, USP Coreg® Tablets
Beta-Adrenergic Blocking Agents Labetalol HCl Tablets, USP Normodyne® Tablets
Beta-Adrenergic Blocking Agents Metoprolol Succinate Extended-Release Tablets, USP Toprol-XL® Extended-Release Tablets
Beta-Adrenergic Blocking Agents Nadolol Tablets, USP Corgard® Tablets
Beta-Adrenergic Blocking Agents Spironolactone Tablets, USP Aldactone® Tablets
Calcium-Channel Blocking Agents Diltiazem HCl Extended-Release Capsules, USP Cardizem® CD Extended-Release Capsules
Cardiovascular Agents Atenolol/Chlorthalidone Tablets, USP Tenoretic® Tablets
Central Nervous System Agents Acamprosate Calcium Delayed-Release Tablets Campral® Delayed-Release Tablets
CentrallyActingSkeletal TizanidineHClCapsules Zanaflex®Capsules Muscle Relaxants
Cholelitholytic Agents Ursodiol Tablets, USP Urso® Forte Tablets
Cholesterol Absorption Inhibitors Ezetimibe Tablets, USP Zetia® Tablets
Dihydropyridines Amlodipine Besylate Tablets, USP Norvasc® Tablets
Disease-modifyingAntirheumatic LeflunomideTablets,USP Arava®Tablets
Diuretics Bumetanide Tablets, USP Bumex® Tablets
Diuretics Ethacrynate Sodium for Injection, USP Edecrin® Injection
Diuretics Triamterene/Hydrochlorothiazide Tablets, USP Maxzide® Tablets
Estrogens and Estrogen Anastrozole Tablets, USP Arimidex® Tablets Agonists-Antagonists
Estrogens and Estrogen Exemestane Tablets Aromasin® Tablets Agonists-Antagonists
First Generation Antihistamines Cyproheptadine HCl Tablets, USP Periactin® Tablets
First Generation Antihistamines Promethazine HCl Tablets, USP Phenergan® Tablets
Therapeutic Category Generic Name Brand Name
34
z y d u s u s a . c o m
Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).
T H E R A P E U T I C C A T E G O R I E S |
Therapeutic Category Generic Name Brand Name
GABA-derivative Skeletal Baclofen Tablets, USP Lioresal® Tablets Muscle Relaxants
HCV Antivirals Hydroxychloroquine Sulfate Tablets, USP Plaquenil® Tablets
Heavy Metal Antagonists Trientine HCl Capsules, USP Syprine® Capsules
Histamine H2-Antagonists Ranitidine Injection, USP Zantac® Injection
Immunosuppressive Agents Azathioprine Tablets, USP Imuran® Tablets
Immunosuppressive Agents Sirolimus Tablets Rapamune® Tablets
Macrolides Azithromycin Oral Suspension, USP Zithromax® Oral Suspension
Neuromuscular Blocking Agents Succinylcholine Chloride Injection, USP Quelicin® Injection
NonsteroidalAnti-inflammatoryAgents EtodolacExtended-ReleaseTablets,USP LodineXL®Extended-ReleaseTablets
NonsteroidalAnti-inflammatoryAgents IndomethacinInjection,USP Indocin®Injection
NonsteroidalAnti-inflammatoryAgents MeloxicamTablets,USP Mobic®Tablets
Opiate Agonists Tramadol HCl Tablets, USP Ultram® Tablets
Opiate Agonists Tramadol HCl/Acetaminophen Tablets, USP Ultracet® Tablets
Parasympathomimetic Pyridostigmine Bromide Tablets, USP Mestinon® Tablets (Cholinergic) Agents
Parasympathomimetic Rivastigmine Transdermal Patch Exelon® Transdermal Patch (Cholinergic) Agents
Parathyroid and Antiparathyroid Agents Desmopressin Acetate Nasal Spray DDAVP® Nasal Spray
PhosphodiesteraseType5Inhibitors VardenafilTablets Levitra®Tablets
Proton-pump Inhibitors Esomeprazole Magnesium Nexium® Delayed-Release Capsules Delayed-Release Capsules, USP
Proton-pump Inhibitors Lansoprazole Delayed-Release Capsules, USP Prevacid® Delayed-Release Capsules
Proton-pump Inhibitors Lansoprazole Delayed-Release Prevacid® SoluTab Delayed-Release Orally-Disintegrating Tablets Orally-Disintegrating Tablets
Proton-pump Inhibitors Omeprazole Delayed-Release Tablets, USP Prilosec® Delayed-Release Capsules
Proton-pump Inhibitors Omeprazole/Sodium Bicarbonate Capsules Zegerid® Capsules
Renin-Angiotensin-Aldosterone Ramipril Capsules, USP Altace® Capsules System Inhibitors
Replacement Preparations Potassium Chloride Extended-Release Tablets, USP K-Tab® Extended-Release Tablets
Replacement Preparations Potassium Citrate Extended-Release Tablets, USP Urocit-K® Extended-Release Tablets
Skin and Mucous Membrane Agents Nitroglycerin Transdermal System Nitroglycerin Transdermal System (AB2 rating)
Urinary Anti-infectives Nitrofurantoin Capsules, USP (Macrocrystals) Macrodantin® Capsules
Vasodilating Agents Ambrisentan Tablets Letairis® Tablets
Vasodilating Agents Bosentan Tablets Tracleer® Tablets
Vasodilating Agents Isosorbide Mononitrate ER Tablets Imdur® Extended-Release Tablets
VasodilatingAgents TadalafilTablets,USP Cialis®Tablets
Vitamin D Paricalcitol Capsules Zemplar® Capsules
Vitamin K Phytonadione Tablets, USP Mephyton® Tablets
35
z y d u s u s a . c o m
| B R A N D T O G E N E R I C G U I D E
Adderall® Tablets Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Adoxa® Tablets Doxycycline Monohydrate Tablets, USP
Albenza® Tablets Albendazole Tablets, USP
Aldactone® Tablets Spironolactone Tablets, USP
Altace® Capsules Ramipril Capsules, USP
Ammonul® Injection Sodium Phenylacetate/Sodium Benzoate Injection
Anafranil® Capsules Clomipramine HCl Capsules, USP
Antizol® Injection Fomepizole Injection
Arava®Tablets LeflunomideTablets,USP
Arimidex® Tablets Anastrozole Tablets, USP
Aromasin® Tablets Exemestane Tablets
Asacol® HD Delayed-Release Tablets Mesalamine Delayed-Release Tablets, USP
Baraclude® Tablets Entecavir Tablets
BiCNU® Injection Carmustine Injection, USP
Bumex® Tablets Bumetanide Tablets, USP
BuSpar® Tablets Buspirone HCl Tablets, USP
Campral® Delayed-Release Tablets Acamprosate Calcium Delayed-Release Tablets
Cardizem® CD Extended-Release Capsules Diltiazem HCl Extended-Release Capsules, USP
Cardura® Tablets Doxazosin Tablets, USP
Cialis®Tablets TadalafilTablets,USP
Clobex® Spray Clobetasol Propionate Spray
Cogentin® Injection Benztropine Mesylate Injection
Copegus® Tablets Ribavirin Tablets
Cordarone® Tablets Amiodarone HCl Tablets
Coreg® Tablets Carvedilol Tablets, USP
Corgard® Tablets Nadolol Tablets, USP
Cozaar® Tablets Losartan Potassium Tablets, USP
Cymbalta® Delayed-Release Capsules Duloxetine Delayed-Release Capsules, USP
DDAVP® Nasal Spray Desmopressin Acetate Nasal Spray
Depakote® Sprinkle Capsules Divalproex Sodium Capsules (Sprinkle), USP
Desyrel® Tablets Trazodone HCl Tablets, USP
Diflucan®Tablets FluconazoleTablets,USP
Brand Name Generic Name
36
BRAND TO GENERIC GUIDE
z y d u s u s a . c o m
B R A N D T O G E N E R I C G U I D E |
Diprosone® Cream Betamethasone Dipropionate Cream, USP
Ditropan XL® Extended-Release Tablets Oxybutynin Chloride Extended-Release Tablets
Doxy 100® Injection Doxycycline Hyclate Injection, USP
Edecrin® Injection Ethacrynate Sodium for Injection, USP
Effexor XR® Extended-Release Capsules Venlafaxine HCl Extended-Release Capsules, USP
Effexor® Tablets Venlafaxine HCl Tablets, USP
Elavil® Tablets Amitriptyline HCl Tablets, USP
Entocort® EC Capusles Budesonide Capsules (Enteric Coated)
Exelon® Transdermal Patch Rivastigmine Transdermal Patch
Flomax® Capsules Tamsulosin HCl Capsules, USP
Glucophage® Tablets Metformin HCl Tablets, USP
Glucotrol® XL Extended-Release Tablets Glipizide Extended-Release Tablets
Haloperidol Tablets, USP Haloperidol Tablets, USP
Imdur® Extended-Release Tablets Isosorbide Mononitrate ER Tablets
Imuran® Tablets Azathioprine Tablets, USP
Indocin® Injection Indomethacin Injection, USP
Jalyn® Capsules Dutasteride/Tamsulosin HCl Capsules
K-Tab® Extended-Release Tablets Potassium Chloride Extended-Release Tablets, USP
Lamictal® Tablets Lamotrigine Tablets, USP
Letairis® Tablets Ambrisentan Tablets
Levitra®Tablets VardenafilTablets
Lialda® Delayed-Release Tablets Mesalamine Delayed-Release Tablets
Lioresal® Tablets Baclofen Tablets, USP
Lipitor® Tablets Atorvastatin Calcium Tablets, USP
Lodine XL® Extended-Release Tablets Etodolac Extended-Release Tablets, USP
Macrodantin® Capsules Nitrofurantoin Capsules, USP (Macrocrystals)
Maxzide® Tablets Triamterene/Hydrochlorothiazide Tablets, USP
Medrol® Tablets Methylprednisolone Tablets, USP
Mephyton® Tablets Phytonadione Tablets, USP
Mestinon® Tablets Pyridostigmine Bromide Tablets, USP
Metaglip® Tablets Glipizide/Metformin HCl Tablets, USP
Micardis® Tablets Telmisartan Tablets, USP
Minocin® Capsules Minocycline HCl Capsules, USP
Brand Name Generic Name
37
z y d u s u s a . c o m
| B R A N D T O G E N E R I C G U I D E
Mobic® Tablets Meloxicam Tablets, USP
Monodox® Capsules Doxycycline Monohydrate Capsules, USP
Neurontin® Tablets Gabapentin Tablets, USP
Nexium® Delayed-Release Capsules Esomeprazole Magnesium Delayed-Release Capsules, USP
Nitroglycerin Transdermal System (AB2 rating) Nitroglycerin Transdermal System
Nolvadex® Tablets Tamoxifen Citrate Tablets, USP
Normodyne® Tablets Labetalol HCl Tablets, USP
Norvasc® Tablets Amlodipine Besylate Tablets, USP
Onfi®Tablets ClobazamTablets
Parlodel® Capsules Bromocriptine Mesylate Capsules, USP
Paxil® Tablets Paroxetine Tablets, USP
Periactin® Tablets Cyproheptadine HCl Tablets, USP
Phenergan® Tablets Promethazine HCl Tablets, USP
Plaquenil® Tablets Hydroxychloroquine Sulfate Tablets, USP
Pravachol® Tablets Pravastatin Sodium Tablets, USP
Prevacid® Delayed-Release Capsules Lansoprazole Delayed-Release Capsules, USP
Prevacid® SoluTab Delayed-Release Lansoprazole Delayed-Release Orally-Disintegrating Tablets Orally-Disintegrating Tablets
Prilosec® Delayed-Release Capsules Omeprazole Delayed-Release Tablets, USP
Quelicin® Injection Succinylcholine Chloride Injection, USP
Questran® Light Powder for Suspension Cholestyramine Light Powder for Suspension
Questran® Powder for Suspension Cholestyramine Powder for Suspension, USP
Rapamune® Tablets Sirolimus Tablets
Rebetol® Capsules Ribavirin Capsules, USP
Relpax® Tablets Eletriptan HBr Tablets
Rheumatrex® Tablets Methotrexate Tablets, USP
Risperdal® Tablets Risperidone Tablets, USP
Roxicodone® Tablets Oxycodone HCl Tablets, USP
Rozerem® Tablets Ramelteon Tablets
Starlix® Tablets Nateglinide Tablets, USP
Symmetrel® Capsules Amantadine HCl Capsules, USP
Syprine® Capsules Trientine HCl Capsules, USP
Tamiflu®Capsules OseltamivirPhosphateCapsules,USP
Tamiflu®forSuspension OseltamivirPhosphateforSuspension
Brand Name Generic Name
38
BRAND TO GENERIC GUIDE
z y d u s u s a . c o m
B R A N D T O G E N E R I C G U I D E |
Temodar® Capsules Temozolomide Capsules
Temovate® Cream Clobetasol Propionate Cream, USP
Temovate® Ointment Clobetasol Propionate Ointment, USP
Tenoretic® Tablets Atenolol/Chlorthalidone Tablets, USP
Tenormin® Tablets Atenolol Tablets, USP
Tessalon® Perles Benzonatate Capsules, USP
Topamax® Sprinkle Capsules Topiramate Capsules (Sprinkle), USP
Topamax® Tablets Topiramate Tablets, USP
Topicort® Ointment Desoximetasone Ointment, USP
Toprol-XL® Extended-Release Tablets Metoprolol Succinate Extended-Release Tablets, USP
Tracleer® Tablets Bosentan Tablets
TriCor®Tablets FenofibrateTablets
Trisenox® Injection Arsenic Trioxide Injection
Ultracet® Tablets Tramadol HCl/Acetaminophen Tablets, USP
Ultram® Tablets Tramadol HCl Tablets, USP
Urocit-K® Extended-Release Tablets Potassium Citrate Extended-Release Tablets, USP
Urso® Forte Tablets Ursodiol Tablets, USP
Vfend® Tablets Voriconazole Tablets
Virazole® for Inhalation Solution Ribavirin for Inhalation Solution, USP
Wellbutrin® XL Extended-Release Tablets Bupropion HCl Extended-Release Tablets, USP
Zanaflex®Capsules TizanidineHClCapsules
Zantac® Injection Ranitidine Injection, USP
Zegerid® Capsules Omeprazole/Sodium Bicarbonate Capsules
Zemplar® Capsules Paricalcitol Capsules
Zetia® Tablets Ezetimibe Tablets, USP
Zithromax® Oral Suspension Azithromycin Oral Suspension, USP
Zomig-ZMT® Orally Disintegrating Tablets Zolmitriptan Orally Disintegrating Tablets
Zovirax® Ointment Acyclovir Ointment, USP
Zovirax® Tablets Acyclovir Tablets, USP
Zyloprim® Tablets Allopurinol Tablets, USP
Brand Name Generic Name
39
z y d u s u s a . c o m
Customer Service:Zydus Pharmaceuticals (USA) Inc.73 Route 31 NorthPennington, NJ 08534
Hours of Operation:9:00 AM - 5:00 PM EST, Monday-Friday
Phone:877-ZYDUS RX, Prompt 1 (877-993-8779, Prompt 1)
Fax:877-993-9055
Remit To:Zydus Pharmaceuticals (USA) Inc.73 Route 31 NorthPennington, NJ 08534
Minimum Order Requirements:The minimum order for each SKU is one case pack (usually a quantity of 12 or 24). The total order must exceed $1,000.00.All orders will be shipped on a prepaid basis utilizing the method of transportation selected by Zydus Pharmaceuticals. In cases where customer requests are expedited, more expensive, or special handling of an order, Zydus Pharmaceuticals reserves the right to charge the customer for these expenses.
ORDERING INFORMATION
| O R D E R I N G I N F O R M A T I O N40
z y d u s u s a . c o m
ZYDUS PHARMACEUTICALS (USA) INC. RETURN GOODS POLICYCustomer Service:This return goods policy applies to all ZyGeneric (68382), (70710) and Nesher (51477) labeled pharmaceutical products. All ZyGeneric and Nesher product returns must be sent prepaid to our designated return goods processor to the following address: Inmar- South Dock, 4332 Empire Road, Fort Worth, TX 76155. Zydus does not pay fees such as processing charges for returning any product other than recalled product. For customers using other return companies for processing and destruction Zydus will not assume responsibility for charges incurred.
Request for Return Authorizations (box labels) can be made by any of the below methods:1. Accessing the Inmar website at https://clsnetlink.com (you will need to upload a PDF copy of your
debit memo)2. E-mail your debit memo to [email protected]. Be sure to include NDC#, lot# and expiration
dates assigned to each item.3. Fax your debit memo to Inmar at 817-868-5343
Returnable Items (For Reimbursement):• Products within six (6) months of expiration date and up to 12 months after the expiration date stated on
the package. Products must be in sealed, full, unopened, original Zydus or Nesher containers.• Products received in error or damaged in shipping to consignee (accompanied by a signed bill of lading
noting such damage) if reported to Zydus customer service within 5 days of receipt and returned within 30 days
• Prior written approval is required for all return of all overstocked product with greater than 12 months expiration dating. This merchandise will be subject to a 15% restocking fee.
• A DEA Form 222 is required in order to return C-II controlled substances. Please send DEA Form 222 requests to: Fax # (817) 868-5342 or E-mail: [email protected]
Returnable Items (No Credit):• Products returned without an approved Product Return Form• Products sold on a non-returnable basis, professional sample, or free goods• Partial or open bottles, except where required by law•Productwhichhasbeenrepackaged,productpurchasedthroughabankruptcysale,firesale,distress
merchandise, or product not in original container are not eligible for credit. Zydus will not credit for productdamagedduetoinsurablecausessuchasfire,floodsorearthquake.
• Products with broken seals, opened, coded, dated, damaged or missing label, or soiled packages• Products damaged at customer’s warehouse or store, or not stored under proper conditions• Products with greater than six months expiration dating or are greater than 12 months past the
expiration date• Private label products• Return of over stocked product without prior written approval of Zydus• Merchandise distributed contrary to federal, state or local laws• Product not purchased from either Zydus or the customer’s authorized distributor / wholesaler
R E T U R N G O O D S P O L I C Y | 41
z y d u s u s a . c o m
RETURN GOODS POLICY (cont)
Valuation of Returns:• Direct buying customers will be issued a credit by Zydus. This credit will be issued at the lowest
of either original invoice price or the prevailing contract price on the date the goods are returned to Zydus.
• Non-Direct customers will receive credit directly from Inmar. If no contract exists, the credit will be issued based upon the lower of the current Zydus standard market price at the time the returned merchandise is received by Inmar OR the original Zydus contract price at point of purchase from the wholesaler.
Transportation Charges:• Prepaid by customer, unless shipped in error by Zydus• Returned product shipped collect will be refused
Miscellaneous:• Representatives cannot authorize return of in date product or pick up merchandise•Returnedproductswillbepromptlyevaluatedandcreditwillreflecteligibilityand/or
ineligibility. All products returned, whether eligible for credit or not, become property of Zydus.Allproductsarereturnedwiththeunderstandingthattheyaresubjecttofinalreviewand evaluation by Zydus, and will be processed in accordance with the most recent return policy in effect at the time of the return.
• Wholesalers are not authorized to accept returns of Zydus products except in the case of mis-shipments or other ordering errors
• Return chargebacks will be paid on original invoice date• Zydus reserves the right to amend this policy at any time• Claim merchandise-even exchange or credit will be allowed for loss or damage evident atdeliverytimeifnotedonthecarrier’deliveryreceiptandreportedtouswithinfivedays.Concealed loss or damage must be inspected by carrier within 15 days after delivery and carrier’s inspection report must be forwarded to Zydus USA.
• Zydus USA policy strictly prohibits any sales representative or any other employee from giving samples or stock packages to any customer to replace merchandise. All returns must be made according to this return goods policy.
| R E T U R N G O O D S P O L I C Y42
z y d u s u s a . c o m
Address Zydus Pharmaceuticals (USA) Inc. 73 Route 31 North Pennington, NJ 08534
Telephone: 609-730-1900 Fax: 609-730-1998 Website: www.zydususa.com
Customer Service Telephone: 877-993-8779, Prompt 1 Fax: 877-993-9055 Email: [email protected]
Medical Affairs Telephone: 877-993-8779, Prompt 2 Fax: 678-581-4401 Email: [email protected]
Returns Inmar: 800-967-5952
CONTACT INFORMATION
C O N T A C T I N F O R M A T I O N | 43
z y d u s u s a . c o m
www.zydususa.com
Zydus Pharmaceuticals (USA) Inc.73 Route 31 N.Pennington, NJ 08534(877) ZYDUS RX or (877) 993-8779